Track topics on Twitter Track topics that are important to you
Howard A. "Skip" Burris, III, MD, FACP, FASCO, discusses the progress that has been made in metastatic triple-negative breast cancer and the work being done to broaden the utility of novel approaches.
Original Article: Metastatic TNBC Paradigm Continues to Evolve With Novel TreatmentsNEXT ARTICLE
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...